Oh, those weekends, don’t you just love them? They provide us with an opportunity to spend time with our families, drive to the country house or go to the theater. Now, we know they also provide us with an increased opportunity to die in a hospital. Research shows that men with metastatic prostate cancer who [...]
I attend the American Society of Clinical Oncology (ASCO) meeting in Chicago in May. As usual, it was exciting and it provides me with a fantastic opportunity to catch up with the current research in advanced prostate cancer. It also gives me an opportunity to meet with and have private conversations with some of the [...]
In the treatment of prostate cancer the first very expensive drug we had that was FDA approved was Provenge, with an initial cost of $93,000 for a one-month’s treatment protocol. Today, the cost is in excess of $106,000. According to the phase III clinical trial result Provenge extends life by a median of 4.1 months, [...]
In a study performed in the UK researchers explored how men with advanced prostate cancer support their personal well being. The study analyzed the practices used by five (5) men with advanced prostate cancer to maintain their emotional wellbeing. Information about the men’s individual practices was taken from face-to-face, semi-structured, in-depth interviews with the five [...]
Starting androgen deprivation therapy (ADT) to treat advanced prostate cancer is usually the start of a long treatment period that will continue for many years, actually until you die. Since our goal in cancer treatment is to make cancer a chronic illness and since prostate cancer does progress for most men in a relatively slow [...]